Cloud Zoom small image
基因改造iPSC源的神经干细胞MAPT V337M HET   英国Axol  ax0323

现价: 0.00
当前销售数量: 143


  • 产品描述
  • 产品特性
  • 评价

axolGEM iPSC-Derived Neural Stem Cells MAPT V337M HET (1.5 million cells) and Neural Plating-XF Medium (30 mL)

Human iPSC-Derived Neural Stem Cells that have been genetically edited using CRISPR-Cas9 technology to introduce the V337M mutation (GTG>ATG) in the MAPT gene. This line is heterozygous for the V337M mutation where 1 allele has the mutation and the other allele is wild type. Click on the product images to see the data and further details. 

The V337M mutation in MAPT has been implicated in frontotemporal dementia and may have a role in Alzheimer's disease. The mutation leads to accelerated aggregation of MAPT/tau protein into filament structures (Nacharaju et al., 1999) and makes the MAPT/tau protein more susceptible to hyperphosphorylation (Alonso et al., 2004). 

Starting material Dermal fibroblast
Donor gender Female
Donor age at sampling 64 yrs
Karyotype Normal
Reprogramming method Episomal vector
Induction method Monolayer & chemically defined medium
Genetic modification Heterozygous for the MAPT V337M mutation (GTG>ATG)
Genetic modification Contains a puromycin resistance cassette (intronic)
Size ≥1.5 million cells
Kit components 1 vial of Neural Stem Cells (≥1.5 million cells) and 1 bottle of Neural Plating-XF Medium (30 mL)
Growth properties Adherent
Shipping conditions Dry ice
Storage conditions Liquid nitrogen